MiR-106b has been found to regulate cellular cholesterol efflux by targeting ABCA1 in macrophages [37], miR-106 plays a role in various dystrophies such as facioscapulohumeral muscular dystrophy, limb-girdle muscular dystrophies, and Miyoshi myopathy [38]. Here, ABCA1 is linked to facioscapulohumeral muscular dystrophy.